Family planning and pregnancy issues for women with systemic inflammatory diseases: Patient and physician perspectives

BMJ Open

Volumn 4, Issue 2, 2014, Pages

  Chakravarty, Eliza ^a   Clowse, Megan E B ^b   Pushparajah, Daphnee S ^c   Mertens, Sarah ^c   Gordon, Caroline ^d  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UCB PHARMA   (Belgium)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL PRACTICE; FAMILY PLANNING; FEMALE; FRANCE; GASTROENTEROLOGIST; GENERAL PRACTITIONER; GERMANY; GYNECOLOGIST; HEALTH SURVEY; HUMAN; INFLAMMATORY DISEASE; ITALY; MAJOR CLINICAL STUDY; MIDDLE AGED; ONLINE ANALYSIS; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT SATISFACTION; PHYSICIAN ATTITUDE; PREGNANCY; PREMENOPAUSE; RHEUMATOLOGY; SPAIN; SYSTEMIC DISEASE; UNITED KINGDOM; UNITED STATES; YOUNG ADULT; CHRONIC DISEASE; CLINICAL TRIAL; COMPLICATION; DOCTOR PATIENT RELATION; GASTROINTESTINAL DISEASE; IMMUNOLOGY; MULTICENTER STUDY; QUESTIONNAIRE; RHEUMATIC DISEASE;

ADULT; CHRONIC DISEASE; FAMILY PLANNING SERVICES; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; MIDDLE AGED; PHYSICIAN-PATIENT RELATIONS; PREGNANCY; RHEUMATIC DISEASES; SURVEYS AND QUESTIONNAIRES;

EID: 84896869009     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-004081     Document Type: Article

References (32)

1. Symmons D, Turner G, Webb R, et al. The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century. Rheumatology 2002;41:793-800. (Pubitemid 34822963)
2. Symmons DP. Epidemiology of rheumatoid arthritis: determinants of onset, persistence and outcome. Best Pract Res Clin Rheumatol 2002;16:707-22.
3. Carbone LD, Cooper C, Michet CJ, et al . Ankylosing spondylitis in Rochester, Minnesota, 1935-1989. Is the epidemiology changing? Arthritis Rheum 1992;35:1476-82. (Pubitemid 23013655)
4. Sieper J, Braun J. Ankylosing spondylitis in clinical practice. Springer-Verlag London Limited, 2011.
5. Binder V. Epidemiology of IBD during the twentieth century: an integrated view. Best Pract Res Clin Gastroenterol 2004;18:463-79. (Pubitemid 38667460)
6. Gollop JH, Phillips SF, Melton LJ, et al. Epidemiologic aspects of Crohn's disease: a population based study in Olmsted County, Minnesota, 1943-1982. Gut 1988;29:49-56. (Pubitemid 18053187)
7. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004;126:1504-17.
8. Klippel JH. Systemic lupus erythematosus: demographics, prognosis, and outcome. J Rheumatol Suppl 1997;48:67-71.
9. Bush MC, Patel S, Lapinski RH, et al. Perinatal outcomes in inflammatory bowel disease. J Matern Fetal Neonatal Med 2004;15:237-41. (Pubitemid 38686012)
10. Morales M, Berney T, Jenny A, et al. Crohn' s disease as a risk factor for the outcome of pregnancy. Hepatogastroenterology 2000;47:1595-8.
11. Ostensen M. Sex hormones and pregnancy in rheumatoid arthritis and systemic lupus erythematosus. Ann N Y Acad Sci 1999;876:131-43; discussion 44.
12. Baird DD, Narendranathan M, Sandler RS. Increased risk of preterm birth for women with inflammatory bowel disease. Gastroenterology 1990;99:987-94. (Pubitemid 20338455)
13. van Dunne FM, Lard LR, Rook D, et al. Miscarriage but not fecundity is associated with progression of joint destruction in rheumatoid arthritis. Ann Rheum Dis 2004;63:956-60. (Pubitemid 38961921)
14. Jawaheer D, Zhu JL, Nohr EA, et al. Time to pregnancy among women with rheumatoid arthritis. Arthritis Rheum 2011;63:1517-21.
15. Mayberry JF, Weterman IT. European survey of fertility and pregnancy in women with Crohn's disease: a case control study by European collaborative group. Gut 1986;27:821-5. (Pubitemid 16058502)
16. Manosa M, Navarro-Llavat M, Marin L, et al. Fecundity, pregnancy outcomes, and breastfeeding in patients with inflammatory bowel disease: a large cohort survey. Scand J Gastroenterol 2013;48:427-32.
17. Vermeire S, Carbonnel F, Coulie PG, et al. Management of inflammatory bowel disease in pregnancy. J Crohns Colitis 2012;6:811-23.
18. Mahadevan U, Cucchiara S, Hyams JS, et al. The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organisation: pregnancy and pediatrics. Am J Gastroenterol 2011;106:214 -23; quiz 24.
19. Ng SW, Mahadevan U. Management of inflammatory bowel disease in pregnancy. Expert Rev Clin Immunol 2013;9:161-74.
20. Ostensen M, Forger F. Management of RA medications in pregnant patients. Nature Rev Rheumatol 2009;5:382-90.
21. Syme MR, Paxton JW, Keelan JA. Drug transfer and metabolism by the human placenta. Clin Pharmacokinet 2004;43:487-514. (Pubitemid 38858303)
22. Buckley LM, Bullaboy CA, Leichtman L, et al. Multiple congenital anomalies associated with weekly low-dose methotrexate treatment of the mother. Arthritis Rheum 1997;40:971-3. (Pubitemid 27200016)
23. Lloyd ME, Carr M, McElhatton P, et al. The effects of methotrexate on pregnancy, fertility and lactation. QJM 1999;92:551-63. (Pubitemid 29501961)
24. Brent RL. Teratogen update: reproductive risks of leflunomide (Arava); a pyrimidine synthesis inhibitor: counseling women taking leflunomide before or during pregnancy and men taking leflunomide who are contemplating fathering a child. Teratology 2001;63:106-12.
25. Chakravarty EF, Sanchez-Yamamoto D, Bush TM. The use of disease modifying antirheumatic drugs in women with rheumatoid arthritis of childbearing age: a survey of practice patterns and pregnancy outcomes. J Rheumatol 2003;30:241-6. (Pubitemid 36152584)
26. Langen ES, Chakravarty EF, Liaquat M, et al. High rate of preterm birth in pregnancies complicated by rheumatoid arthritis. Am J Perinatol 2013;31:9-14.
27. Hameen-Anttila K, Jyrkka J, Enlund H, et al. Medicines information needs during pregnancy: a multinational comparison. BMJ open 2013;3:e002594.
28. Peters SL, Lind JN, Humphrey JR, et al. Safe lists for medications in pregnancy: inadequate evidence base and inconsistent guidance from Web-based information, 2011. Pharmacoepidemiol Drug Saf 2013;22:324-8.
29. Toomey D, Waldron B. Family planning and inflammatory bowel disease: the patient and the practitioner. Fam Pract 2013;30:64-8.
30. van der Woude CJ, Kolacek S, Dotan I, et al. European evidenced-based consensus on reproduction in inflammatory bowel disease. J Crohns Colitis 2010;4:493-510.
31. Finer LB, Henshaw SK. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect Sex Reprod Health 2006;38:90-6. (Pubitemid 43882311)
32. Panchal S, Khare M, Moorthy A, et al. Catch me if you can: a national survey of rheumatologists and obstetricians on the use of DMARDs during pregnancy. Rheumatol Int 2013;33:347 -53.